Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001193125-20-029762
Filing Date
2020-02-10
Accepted
2020-02-10 16:07:08
Documents
2
Group Members
CORRIENTE MASTER FUND II, LPMARK L. HART III

Document Format Files

Seq Description Document Type Size
1 SC 13G/A d883348dsc13ga.htm SC 13G/A 76512
2 EX-99.A d883348dex99a.htm EX-99.A 3140
  Complete submission text file 0001193125-20-029762.txt   81274
Mailing Address 1401 FOCH ST SUITE 100 FORT WORTH TX 76107
Business Address 1401 FOCH ST SUITE 100 FORT WORTH TX 76107 8178700400
Corriente Advisors, LLC (Filed by) CIK: 0001406718 (see all company filings)

EIN.: 752939516 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address ONE KENDALL SQUARE BLDG. 1400E, SUITE B14202 CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE BLDG. 1400E, SUITE B14202 CAMBRIDGE MA 02139 617-349-1971
CATABASIS PHARMACEUTICALS INC (Subject) CIK: 0001454789 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-88910 | Film No.: 20591942
SIC: 2834 Pharmaceutical Preparations